Company profilePharmaceutical#466 of 1,318 in Pakistan1 DRAP alert

LEAMA CHEMI PHARMA (PVT.) LTD.

Pharmaceutical company · 31 brands · 40 molecules

Ranked #61 of 146 companies in Antiemetics & Antinauseants

31 registered products 25 pharmaceutical brands 40 distinct molecules 1 DRAP alert

Company overview

31
registered products
25
pharmaceutical brands
40
distinct molecules
5
therapeutic classes
1
DRAP alerts

LEAMA CHEMI PHARMA (PVT.) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 31 product registrations across 40 distinct molecules. Its portfolio is concentrated in Antiemetics & Antinauseants and Antidiarrheals, Intestinal Antiinflammatory/Antiinfective. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Therapeutic classes

Antiemetics & Antinauseants · 2Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 1Antacid · 1Vitamin B Complex Plain & With Vitamin C · 1Quinolone Antibacterials · 1

Regulatory record

1 alert in the DRAP feed we track.

Drug Product Recall: Lefin Pediatric Suspension (Batch # 332v) by M/s. Leama Chemi Pharma
2021-11-12

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for LEAMA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.